Volume 154, Issue 8, Pages (June 2018)

Slides:



Advertisements
Similar presentations
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Advertisements

MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease  Jason Ferreira, Mona Akbari, Laurie Gashin,
Volume 150, Issue 7, Pages (June 2016)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Huiqin He, Zhinong Jiang, Leimin Sun  Gastroenterology 
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Covering the Cover Gastroenterology
Evaluation and Management of End-Stage Liver Disease in Children
Volume 152, Issue 5, Pages (April 2017)
Genetics and Genomics in the Practice of Medicine
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Volume 147, Issue 5, Pages e3 (November 2014)
Defensins Versus Bacteria: Not Just Antibiotics Anymore
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
Maria Quaranta, Rachel Wilson  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
Arun J. Sanyal, Veronica Miller  Gastroenterology 
Evidence for Life Before Inflammatory Bowel Disease
Clinical Challenges and Images in GI
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 155, Issue 4, Pages (October 2018)
Management of Patients With Functional Heartburn
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Clinical Challenges and Images in GI
Volume 139, Issue 6, Pages (December 2010)
The Genetics of Inflammatory Bowel Disease
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location  Gwen Murphy, Ruth Pfeiffer,
Volume 155, Issue 6, Pages (December 2018)
Volume 153, Issue 4, Pages (October 2017)
Dushyant Singh, Reetu Singh, Wendell K. Clarkston 
Effect of Human Immunodeficiency Virus and Antiretrovirals on Outcomes of Hepatitis C: A Systematic Review From an Epidemiologic Perspective  Jennifer.
Volume 133, Issue 6, Pages (December 2007)
Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease  Jason Ferreira, Mona Akbari, Laurie Gashin,
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Volume 149, Issue 6, Pages (November 2015)
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Volume 150, Issue 7, Pages (June 2016)
Volume 140, Issue 6, Pages e2 (May 2011)
Manuel Romero-Gómez, Javier Ampuero  Gastroenterology 
Jikyoung Lee, Jong Jin Hyun, Hong Sik Lee  Gastroenterology 
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Volume 151, Issue 4, Pages (October 2016)
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Richard Blumberg, Judy Cho, James Lewis, Gary Wu  Gastroenterology 
Volume 139, Issue 1, Pages (July 2010)
Immune Dysfunction and Infections in Patients With Cirrhosis
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
Kalpesh K. Patel, Mark W. Babyatsky  Gastroenterology 
Figure 2 Distribution of DEPDC5 variants in patients and controls
Electronic Clinical Challenges and Images in GI
Alan Huett, Ramnik J. Xavier  Gastroenterology 
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Treating Inflammatory Bowel Disease With Diet: A Taste Test
Volume 146, Issue 4, Pages (April 2014)
Presentation transcript:

Volume 154, Issue 8, Pages 2022-2024 (June 2018) A Spectrum of Genetic Variants Contributes to Immune Defects and Pathogenesis of Inflammatory Bowel Diseases  Holm H. Uhlig  Gastroenterology  Volume 154, Issue 8, Pages 2022-2024 (June 2018) DOI: 10.1053/j.gastro.2018.05.001 Copyright © 2018 AGA Institute Terms and Conditions

Figure 1 The expanding genetic variant spectrum in XIAP. (A) The protein domain structure of XIAP with its 3 baculovirus inhibitor of apoptosis protein repeat (BIR) domains and the ring domain are shown. Genetic nonsynonymous variants and their minor allele frequency (MAF) in the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org) dataset are indicated. The common XIAP variant p.Q423P is neither associated with inflammatory bowel disease (IBD) nor immune dysfunction, and has no clinical consequence. Some of the rare variants with minor allele frequency between 0.00001 and 0.01000 show reduced activity and are statistically associated with IBD owing to their variant burden, but have largely no clinical implications. (B) Ultrarare hemizygous functional variants (stop codon, frameshift, deletions or nonsynonymous amino acid variants in particular affecting the BIR2 domain) with complete or near complete loss-of-function cause immunodeficiency and intestinal inflammation in male individuals (variant data derived from11). Those patients require an interdisciplinary clinical follow-up that is different for the standard of IBD care as well as genetic counseling. (C) Females with heterozygous pathogenic variants are largely nonaffected carriers. Owing to nonrandom X-inactivation of the wild-type XIAP allele, mild clinical presentations are not infrequent and severe phenotypes have been described. Genetic counseling is required as well as a clinical follow-up, dependent on individual cellular protein function and on disease progression. EBV, Epstein-Barr virus. Gastroenterology 2018 154, 2022-2024DOI: (10.1053/j.gastro.2018.05.001) Copyright © 2018 AGA Institute Terms and Conditions